31 August 2016
Ms Sue MacLeman, Managing Director and CEO of MTPConnect, will present on Australia's medtech capabilities and competitive advantages at a medtech showcase in Seoul.
29 August 2016
MTPConnect is delighted to announce the appointment of three General Managers today.
10 August 2016
MTPConnect and ARCS Australia have signed a Memorandum of Understanding (MoU), agreeing to work closely together for the benefit of the MedTech, biotechnology and pharmaceutical industry.
28 July 2016
MTPConnect is looking for collaborative, industry-led projects through a dollar-for-dollar matched Project Fund Program.
25 July 2016
MTPConnect will be touring Australia in July and August 2016 to encourage collaboration for a competitive Australia.
25 July 2016
MTPConnect today launched its Draft Sector Competitiveness Plan.
08 July 2016
Austrade Seoul invites Australian medtech companies to meet with Korean industry at the 2016 Australian Medtech Innovation Showcase in Seoul on the 1-2 September.
01 June 2016
The 2016 Australian Technologies Competition (ATC16) is open for entries to Australian technology SMEs with global potential.
16 May 2016
The National Health and Medical Research Council (NHMRC), with the assistance of a Working Committee of the Australian Health Ethics Committee (AHEC) is revising the 2009 AHEC Position Statement on Monitoring and reporting of safety for clinical trials involving therapeutic products.
12 May 2016
Public Call for submissions of priorities for the Medical Research Futures Fund – Health and Medical Research Branch
On 4 May 2016 the Australian Medical Research Advisory Board supporting the Medical Research Future Fund held its inaugural meeting.
10 May 2016
ARC request feedback on how Universities are translating their research into economic, social and other benefits
The Australian Research Council (ARC) and the Department of Education and Training set to develop and implement this a national engagement and impact assessment examining research translation.
22 February 2016
MTPConnect is pleased to announce that it has appointed Ms Sue MacLeman as Chief Executive Officer. Ms MacLeman will commence in her role April 2016 and will bring energy, expertise and insight to the role.
01 February 2016
As a participant HARTMANN Australia will be able to bring their focus on industry and consumer needs to WoundCRC's research.
10 December 2015
The Australian Government’s $250 million Biomedical Translation Fund will bridge the gap between research and commercialisation of new Australian biomedical discoveries.